State Street SPDR S&P Biotech ETF (XBI) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Broad Market / FactorSector
- $169.5552W High
- $93.4352W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track State Street SPDR S&P Biotech ETF (XBI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $93.43 and a high of $169.55, highlighting its annual price range. Buy and sell State Street SPDR S&P Biotech ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Most Recent News
TSMC posts record August revenue, up 53% YoY, driven by strong AI chip demand
Taiwan Semiconductor Manufacturing Co. (TSMC) reported record monthly revenue of $16.35 billion for August, a 53.3% increase from the previous year and a 10.1% rise from July. The surge is driven by robust demand for chips used in artificial intellig...

Vistra rated Buy at $152 on stronger electricity demand and solid contracts boosting earnings visibility.
Vistra is rated Buy at $152 following a 12% price pullback, improved EBITDA, and a positive outlook driven by growing electricity demand in key US markets like ERCOT and PJM. The company's value is supported by demand from data centers, electrificati...

Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.
Coinbase CEO Brian Armstrong expressed confidence that the Clarity Act, a U.S. federal bill to regulate digital assets, is likely to pass the Senate with broad support from crypto firms and banks. The legislation aims to clarify oversight between the...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.